ALFA Filings
Every announcement, straight from the exchange
Every Jagsonpal Pharmaceuticals employee stock options announcement on NSE and BSE, newest first, each with its own page.
Time
11 announcements with these filters
Jagsonpal Pharmaceuticals Limited allotted 101,825 equity shares upon the exercise of employee stock options. This issuance expands the company's paid-up share capital.
Jagsonpal Pharmaceuticals allotted 1,01,825 equity shares under its 2022 ESOP scheme, valued at Rs. 0.96 Crore upon exercise of vested options.
Jagsonpal Pharmaceuticals Limited allotted 27,950 equity shares following the exercise of employee stock options. This increases the company's total paid-up share capital to Rs. 13.19 Crore.
Jagsonpal Pharmaceuticals has granted 1,20,000 employee stock options under its 2022 ESOP plan. The options carry an exercise price of Rs. 179.25 each.
Jagsonpal Pharmaceuticals allotted 94,000 equity shares under its ESOP scheme. Consequently, the company's paid-up share capital increased to Rs. 13.18 Crore.
Jagsonpal Pharmaceuticals allotted 94,000 equity shares under its 2022 ESOP plan. This exercise increased the paid-up share capital to Rs. 13.19 Crore.
Jagsonpal Pharmaceuticals allotted 2,96,320 equity shares following the exercise of employee stock options. This increases the company's total paid-up share capital to 6,58,35,470 shares.
Jagsonpal Pharmaceuticals allotted 2,96,320 equity shares following ESOP exercises valued at approximately ₹2.92 Crore. This increases the company's total paid-up capital to ₹13.17 Crore.
Jagsonpal Pharmaceuticals Limited granted 1,93,000 employee stock options at an exercise price of Rs. 159.50 each, totaling ₹3.08 Crore. The options vest in four equal annual tranches starting from April 2027. This move aims to align employee interests with long-term shareholder value creation.
Jagsonpal Pharmaceuticals Limited allotted 176,900 equity shares under its ESOP/ESPS scheme on April 13, 2026. This increased the company's paid-up share capital from ₹13.39 Crore to ₹13.43 Crore.
Jagsonpal Pharmaceuticals Limited allotted 1,76,900 equity shares under its JPL ESOP 2022 scheme following the exercise of options by employees. This allotment increased the company's paid-up share capital to ₹13.43 Crore. The shares rank pari-passu with existing equity shares and reflect the company's ongoing employee incentive commitments.